LNLENSAR, Inc. LNSR · NASDAQ
$5.80 -3.81% (-$0.23)
- Market cap
- $74.1M
- Enterprise value
- $62.9M
- P/E
- 2.1x
- Forward P/E
- -
- PEG
- -
- P/S
- 1.2x
- P/FCF
- -
- EV/EBITDA
- 1.8x
- ROIC
- -22.0%
- Gross margin
- 48.0%
- Net margin
- 57.6%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -0.3x
- Beta
- 0.95
- Free float
- 72.0%
About the company
LENSAR, Inc. (LSR) is an American company focused on the development and manufacturing of advanced technologies for surgical ophthalmology. With a product portfolio including innovative surgical systems like the LENSAR® Laser System, LENSAR provides state-of-the-art solutions for cataract procedures. Their technology combines advanced robotics, 3D imaging, and laser energy, enabling precise and personalized surgical interventions for patients. LENSAR, Inc. also emphasizes continuous development and innovation in the field of ophthalmic surgery. Shares of LENSAR, Inc. (LSR) could be suitable for investors seeking opportunities in the healthcare technology sector with a focus on ophthalmic surgery and innovative technologies.
Sector
Healthcare
Industry
Medical - Devices
CEO
Nicholas T. Curtis
Employees
150
Headquarters
Orlando
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number